Roblin, D., Yosipovitch, G., Boyce, B., Robinson, J., Sandy, J., Mainero, V., Wickramasinghe, R., Anand, U. and Anand, P. (2015) “Topical TrkA Kinase Inhibitor CT327 is an Effective, Novel Therapy for the Treatment of Pruritus due to Psoriasis: Results from Experimental Studies, and Efficacy and Safety of CT327 in a Phase 2b Clinical Trial in Patients with Psoriasis”, Acta Dermato-Venereologica, 95(5), pp. 542–548. doi: 10.2340/00015555-2047.